Dr. Laurie H. Glimcher, Cornell’s provost for medical affairs and the Stephen and Suzanne Weiss Dean of the Medical College, has been named president and chief executive officer of the Dana-Farber Cancer Institute.
According to Cornell professor emeritus of food science Joe Regenstein ’65, M.S. ’66, consumer fears about genetically modified food are mostly misplaced. He spoke at Mann Library Feb. 18.
Food banks may soon be able to boost the nutritional value of the food they distribute to the hungry, thanks to a new harvesting model created by Cornell economists.
The Latin American Studies Program holds its inaugural Cornell conference Friday, Feb. 19, with more than 30 research topics and projects presented by faculty, staff and students.
Weill Cornell Medicine researchers report on a new sterilizing device that can be safely used on electronic equipment used in hospitals to reduce risk of infection quicker, easier and cheaper.
Weill Cornell Medicine investigators have discovered a treatment-resistant prostate cancer that resembles small-cell lung cancer rather than typical prostate cancer and may suggest new treatments.
Weill Cornell Medicine, NewYork-Presbyterian and Houston Methodist have established a new collaborative fellowship program to create highly trained bioethicists.
